US Clinical Practice Experience with Eculizumab in Myasthenia Gravis: Acute Clinical Events and Healthcare Resource Utilization

Abstract Background and Objective The terminal complement inhibitor eculizumab is approved in the USA for the treatment of patients with acetylcholine receptor antibody-positive generalized myasthenia gravis (MG). The ELEVATE study aimed to examine clinical-practice outcome data on eculizumab effect...

Full description

Saved in:
Bibliographic Details
Main Authors: Richard J. Nowak (Author), Ali A. Habib (Author), Andrew J. Klink (Author), Srikanth Muppidi (Author), Anju Parthan (Author), S. Chloe Sader (Author), Alexandrina Balanean (Author), Ajeet Gajra (Author), James F. Howard (Author), ELEVATE Study Group (Author)
Format: Book
Published: Adis, Springer Healthcare, 2024-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available